218 related articles for article (PubMed ID: 25981490)
1. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
Estripeaut D; Contreras R; Tinajeros O; Castrejón MM; Shafi F; Ortega-Barria E; DeAntonio R
Vaccine; 2015 Jun; 33(28):3200-7. PubMed ID: 25981490
[TBL] [Abstract][Full Text] [Related]
2. Incidence of hepatitis A in Israel following universal immunization of toddlers.
Dagan R; Leventhal A; Anis E; Slater P; Ashur Y; Shouval D
JAMA; 2005 Jul; 294(2):202-10. PubMed ID: 16014594
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Hepatitis A in Argentina after vaccination.
Vacchino MN
J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
[TBL] [Abstract][Full Text] [Related]
7. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
Li RC; Li Y; Yi N; Huang L; Wan Z; Zhang Y; Rasuli A
Pediatr Infect Dis J; 2013 Feb; 32(2):e77-81. PubMed ID: 23334341
[TBL] [Abstract][Full Text] [Related]
8. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.
Stuurman AL; Marano C; Bunge EM; De Moerlooze L; Shouval D
Hum Vaccin Immunother; 2017 Mar; 13(3):724-736. PubMed ID: 27786671
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hepatitis A in the United States in the era of vaccination.
Wasley A; Samandari T; Bell BP
JAMA; 2005 Jul; 294(2):194-201. PubMed ID: 16014593
[TBL] [Abstract][Full Text] [Related]
12. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility of universal hepatitis A vaccination in Canada.
Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
[TBL] [Abstract][Full Text] [Related]
14. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
15. Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children.
López EL; Contrini MM; Mistchenko A; Kieffer A; Baggaley RF; Di Tanna GL; Desai K; Rasuli A; Armoni J
Pediatr Infect Dis J; 2015 Apr; 34(4):417-25. PubMed ID: 25764099
[TBL] [Abstract][Full Text] [Related]
16. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
Tsou TP; Liu CC; Huang JJ; Tsai KJ; Chang HF
Vaccine; 2011 Apr; 29(16):2956-61. PubMed ID: 21329774
[TBL] [Abstract][Full Text] [Related]
17. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
[TBL] [Abstract][Full Text] [Related]
18. Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina.
Vizzotti C; Pippo T; Urueña A; Altuna J; Palópoli G; Hernández ML; Artola MF; Fernández H; Orellano P; Cañero-Velasco MC; Ciocca M; Ramonet M; Diosque M
Vaccine; 2015 May; 33 Suppl 1():A227-32. PubMed ID: 25919166
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for acute viral hepatitis--United States, 2006.
Wasley A; Grytdal S; Gallagher K;
MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]